ClinicalTrials.gg
RecruitingNCT06966375WYSHUpdated Nov 18, 2026

Worldwide Yearly Screening for Hypospadias

An interventional study of WYSH Web Application in Hypospadias, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Open to male participants aged 5 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 3 months later.
Updated Nov 18, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
5 Years to 65 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Hypospadias with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Hypospadias · United States.

Planned enrollment
15th of 18
20 · median 67
Started
2025
with 2 others
No phase
14 of 20
4 open now
Registered
19th of 20
by date

Among the 20 studies in Hypospadias with a site in United States, this one is the 15th largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2025, is one of 14 with no phase, and was the 19th registered.

Hypospadias

124 studies on the registry are indexed under Hypospadias; 35 are open to participants now.

Browse Hypospadias studies →

Open to participants now

4 of the 20 studies in Hypospadias with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 20 Hypospadias studies recruiting now, 4 (20%) set no upper age limit and 16 (80%) stop at 75 or younger; 18 take children under 18; 3 take healthy volunteers.

This study: 5 Years to 65 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Hypospadias with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.

Read the detailed description

Several studies show that patients who undergo hypospadias repair report significant functional and psychosexual issues in adolescence or adulthood (in more than 50% of cases). The Care Planning tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application, developed using expert level consensus from a Delphi Measure including stakeholders (psychologists, urologists, endocrinologists, patients/families), is designed to support the functional and psychosexual health of male youth and adults treated for hypospadias, to support their physical and mental health after repair.

This is a pilot study of the WYSH intervention to access its feasibility and acceptability.

[Potential participants can enroll at their local clinic.]

03

Conditions studied

  • Hypospadias

Browse trials for

Keywords

  • Hypospadias Complications
  • Quality of Life
  • Patient-Reported Outcomes
04

Who can participate

The criteria were revised on the registry on Oct 1, 2026. See what changed

Ages eligible
5 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males who have a documented history of repaired hypospadias.
  • Age groups targeted, based on recommended standards for user experience data from pilot studies:

    • 3-5 Males, age 0-4 (with parental consent)
    • 3-5 Males, age 5-10 (with parental consent and child assent)
    • 3-5 Males, age 11-15 (with parental consent and child assent)
    • 3-5 Males, age 16-20 (with parent consent, child assent until age 18)
    • 3-5 Males, age 21-65

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Male Participants with Repaired Hypospadias

    * 3-5 Males, age 0-4 (with parental consent) * 3-5 Males, age 5-10 (with parental consent and child assent) * 3-5 Males, age 11-15 (with parental consent and child assent) * 3-5 Males, age 16-20 (with parent consent, child assent until age 18) * 3-5 Males, age 21-65

    Other: WYSH Web Application

Interventions

  • OtherWYSH Web Application

    Worldwide Yearly Screening for Hypospadias (WYSH) Web Application

06

What researchers measure

Primary outcomes

  1. Feasibility: Participant Count to Summarize answers of the Care Planning Tool

    The Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Application is a survey containing forty-eight questions regarding possible complications for participating patients (Subsections of penile function, voiding, sexual health, social functioning, psychological health, and doctor-patient communication). These questions will be completed by patients using a five point scale - "Never," "Rarely," "Sometimes," "Often," and "Always" - to populate a Care Plan highlighting areas of concern (with a threshold of two or more metrics above a "Sometimes" response).

    Time frame: Baseline, 3 weeks, 3 months

  2. Acceptability: User Centered Metrics

    Participating patients will complete a survey regarding the System Usability to determine ease of functionality throughout the application. This survey contains a scale for participants to graph their response from "Very Difficult" to "Very Easy" following the eleven questions of task completion. Additionally, there is a space provided for open-ended feedback.

    Time frame: Baseline, 3 weeks, 3 months

  3. Acceptability: Cognitive Debriefing Measures

    A team from the Wisconsin Surgical Outcomes Research Program (WiSOR) will complete a Cognitive Debriefing Interview with participating patients to assist in determining validation and comprehension. This interview consists of seven open-ended questions regarding participants' thought processes to provide an insight into areas of improvement for the application. Answers will be coded and themes summarized by participant count.

    Time frame: Baseline, 3 weeks, 3 months

  4. Feasibility: System Usability Testing

    The Center for User Experience will conduct masked System Usability Testing to provide user-based information on how to improve the online experience for young males and their caregivers and adult males. Usability will be assessed with a level of success rating from "Failure," "Success with a major issue," "Success with a minor issue," and "Complete Success," where minor or major issues and time taken are observed as the participating patient is completing the System Usability Scale.

    Time frame: Baseline, 3 weeks, 3 months

Secondary outcomes

  1. Provider Acceptability: Usability Scale

    Participating UW Clinicians will rate the recommendations received in each care plan from patients in a separate usability scale (Provider Acceptability) to improve the ability for continuity of care. Providers will complete a survey of questions surrounding format, output, and utility from "Strongly Disagree" to "Strongly Agree." Additionally, there is a space provided for feedback.

    Time frame: Data collected after participating patient completes questionnaire, up to approximately 3 months.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data collected during pilot testing, after deidentification, will be accessible in the form of text, tables, publications, figures, etc. to disseminate efficacy of the Care Planning tool within the application.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Deidentified individual personal data and supporting information will be made available immediately after publication.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Apr 2027, 21 months after the start.

Of 60 non-industry interventional studies with no phase under Hypospadias, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 21 months is above that.

Counting every sponsor, half of 60 studies reached it within 15 months; a quarter within 8 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Nov 2026 → Apr 2027 and completion Nov 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 2, 2025
First posted
May 11, 2025
StartActual
Jul 23, 2025
Primary completionEst.
Apr 2027was Nov 2026
CompletionEst.
Apr 2027was Nov 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Nov 2026→Apr 2027
Nov 18, 2026
Study completion
Nov 2026→Apr 2027
Nov 18, 2026
Eligibility
1 inclusion criterion added
What changed in the criteria
Inclusion criteria
  • Added3-5 Males, age 0-4 (with parental consent)
Oct 1, 2026
Show all 2 updates
  1. Nov 18, 2026
    Primary completion Nov 2026→Apr 2027
    Study completion Nov 2026→Apr 2027
  2. Oct 1, 2026
    Eligibility 1 inclusion criterion added
    What changed in the criteria
    Inclusion criteria
    • Added3-5 Males, age 0-4 (with parental consent)
    + 3 other changes: identifiers, verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06966375
Responsible party
Sponsor
First posted
May 11, 2025
Start date
Jul 23, 2025
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Haley Lange
Contact
wysh@urology.wisc.edu
wysh@urology.wisc.edu
Vinaya Bhatia, MD
principal investigator · UW School of Medicine and Public Health

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion